Results 111 to 120 of about 195,293 (269)
Watermelon lycopene and allied health claims [PDF]
Presently, functional foods and nutraceuticals are gaining immense importance in the prevention of various maladies through dietary regimen module. Consumption of fruits and vegetables based diet has pursuit a range of bioactive components, especially ...
Butt, Masood Sadiq +4 more
core
A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients [PDF]
BACKGROUND: The previously published ODYSSEY ESCAPE trial demonstrated a significant reduction in the use of lipoprotein apheresis for heterozygous familial hypercholesterolemia (HeFH) patients when placed on alirocumab 150 mg every 2 weeks.
Babirak, Stephan P +10 more
core +1 more source
Role of LDL apheresis in a case of homozygous familial hypercholesterolemia
T. Naveen +8 more
openalex +1 more source
CLINICAL APPLICATION OF HELP-APHERESIS IN FEMALE PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
Cardiovascular diseases caused by atherosclerosis and its complications represent the leading cause of death in developed countries. The main risk factor of atherosclerosis development is dyslipidemia, in particular familial hypercholesterolemia (FH ...
OLGA L. Barbarash +6 more
doaj
Background We assessed long-term real-world effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia (HoFH). Methods Retrospective case series of six patients with HoFH treated with lomitapide in an Italian clinic.
Patrizia Suppressa +3 more
doaj +1 more source
Study of LDL receptor gene mutations in patients with familial hypercholesterolemia in Chaharmahal va Bakhtiari province. [PDF]
چکیده: زمینه و هدف: هایپرکلسترولمی فامیلی (FH) بیماری غالب اتوزومال است که عمدتاً بدلیل جهش در ژن گیرنده لیپوپروتئین با دانسیته کم (LDLR) ایجاد می شود.
Asadi, Somayeh. +9 more
core
Discontinuation of LDL apheresis with evolocumab in an FH patient with a duplication of exon 2-6 in the LDLR gene. [PDF]
Nose D +6 more
europepmc +1 more source
Ezetimibe alone or in combination with simvastatin increases small dense low-density lipoproteins in healthy men: a randomized trial [PDF]
Aims The predominance of small dense low-density lipoproteins (sdLDLs) has been associated with increased cardiovascular risk. The effect of ezetimibe on LDL subfraction distribution has not been fully elucidated.
Berneis, Kaspar +5 more
core

